arrow
C

Charlien Berghen

department of radiation-oncology
H指数:14
被引数:665

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

StereoBed - salvage stereotactic body radiotherapy of the prostate bed for biochemical recurrence after radical prostatectomy: study protocol for a randomized phase II/III trial

StereoBed - 前列腺癌根治术后生化复发患者的体部立体定向放射治疗挽救方案:一项随机II/III期临床试验研究方案

2026-08-290
OA
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial—Results of Secondary Endpoints

肌层浸润性膀胱癌根治性膀胱切除术后辅助放疗:一项2期试验——次要终点结果

2025-02-190
OAAI
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer

ARNEO: 根治性前列腺切除术前加或不加阿帕鲁胺的新辅助地加瑞克治疗高危前列腺癌的随机II期试验

2023-06-0127
PRE
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
2022-12-126
OAAI
Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial

高危肌层浸润性膀胱癌患者根治性膀胱切除术后辅助放疗: 一项多中心II期临床试验的结果

2022-09-0114
OAAI
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial

寡电流淋巴结前列腺癌: 随机PEACE v-storm II期试验的放射治疗质量保证

2022-07-014
OAAI
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
2021-10-1813
OAAI